Transforming Growth Factor-β1 (TGF-β1) Induces Mouse Precartilaginous Stem Cell Proliferation through TGF-β Receptor II (TGFRII)-Akt-β-Catenin Signaling

Li Cheng, Chengyu Zhang, Ding Li, Jian Zou, Junfang WangInternational Journal of Molecular Sciences 2014 · DOI

TL;DR

This study reveals how TGF-β1 promotes the proliferation of precartilaginous stem cells (PSCs) by activating the Akt-GSK3β pathway, leading to β-catenin nuclear accumulation. This, in turn, upregulates the expression of cell cycle genes like cyclin D1 and c-myc, driving PSC growth, which is crucial for bone development.

What Problem Does This Paper Address?

Bone development relies on the ability of precartilaginous stem cells (PSCs) to self-renew and differentiate into chondrocytes. While growth factors like TGF-β1 are known to influence stem cell behavior, the specific mechanisms by which TGF-β1 promotes PSC proliferation and the signaling pathways involved were not well understood. This paper aims to elucidate these mechanisms, providing a deeper understanding of PSC biology and potentially informing strategies for regenerative medicine.

Methods

The researchers employed a multi-pronged approach:

  • PSC Isolation and Culture: They successfully isolated and purified mouse PSCs from the perichondrial mesenchyme using immunomagnetic beads and confirmed their identity via FGFR-3 expression.
  • Western Blotting: This technique was used extensively to detect and quantify protein levels, particularly to assess the phosphorylation status of Akt and GSK3β, and the nuclear translocation of β-catenin.
  • shRNA Knockdown: To investigate the role of specific proteins, TGFRII and β-catenin were selectively silenced using shRNA delivered via lentiviral particles.
  • Pharmacological Inhibition: Specific inhibitors of Akt (perifosine and MK-2206) were used to block Akt activity and observe the downstream effects.
  • 3H-Thymidine Incorporation Assay: This assay was used to measure cell proliferation by quantifying the incorporation of radiolabeled thymidine into newly synthesized DNA.
  • Real-Time PCR: This method was used to measure the mRNA expression levels of key cell cycle genes, cyclin D1 and c-myc.

Datasets

Not discussed in the paper. The study relies on experimental data generated from cell cultures and molecular assays.

Key Insights and Ideas

  • TGF-β1's Proliferation Role: The study definitively shows that TGF-β1 actively promotes the proliferation of mouse PSCs.
  • The Akt-GSK3β-β-Catenin Axis: A critical signaling cascade was identified: TGF-β1 activates Akt, which in turn phosphorylates and inactivates GSK3β. This inactivation of GSK3β prevents the degradation of β-catenin, allowing it to accumulate in the nucleus.
  • Non-Canonical TGF-β Signaling: The findings highlight the importance of non-canonical TGF-β signaling pathways (specifically the Akt pathway) in regulating PSC proliferation, rather than solely relying on the canonical Smad pathway.
  • β-Catenin as a Key Mediator: Nuclear β-catenin was shown to be essential for TGF-β1-induced proliferation, acting as a transcription factor.
  • Target Genes for Proliferation: The study links β-catenin to the upregulation of cyclin D1 and c-myc, genes known to be critical regulators of the cell cycle and cell proliferation.

Key Results

  • TGF-β1 treatment led to increased phosphorylation of Akt and GSK3β in mouse PSCs.
  • TGF-β1 induced the nuclear translocation of β-catenin, which was significantly reduced when TGFRII was knocked down.
  • Inhibiting Akt with perifosine or MK-2206 blocked TGF-β1-induced GSK3β phosphorylation and β-catenin nuclear translocation.
  • Knockdown of β-catenin significantly inhibited TGF-β1-induced PSC proliferation.
  • Both Akt inhibitors and β-catenin knockdown substantially reduced TGF-β1-induced transcription of cyclin D1 and c-myc mRNA.
  • Overall, TGF-β1 treatment significantly increased mouse PSC proliferation, an effect that was attenuated by Akt inhibitors and β-catenin silencing.

Limitations and Future Work

  • In Vitro Focus: The study was conducted in vitro using cultured PSCs. While providing mechanistic insights, in vivo studies would be necessary to confirm these findings in the context of a developing organism.
  • Specific PSC Subtype: The study focused on PSCs derived from the perichondrial mesenchyme. Further research could explore if TGF-β1 acts similarly on other types of stem cells involved in bone development.
  • Canonical vs. Non-Canonical Pathways: While the study emphasizes the non-canonical Akt pathway, a more detailed investigation into the interplay between canonical Smad signaling and this pathway in PSCs could be beneficial.
  • Therapeutic Potential: The findings suggest that targeting the TGF-β1/Akt/β-catenin axis could be a strategy for manipulating PSC proliferation for bone regeneration or treating bone-related disorders. Future work could explore the therapeutic efficacy and safety of such interventions.

Summary updated

Abstract

Precartilaginous stem cells (PSCs) could self-renew or differentiate into chondrocytes to promote bone growth. In the current study, we aim to understand the role of transforming growth factor-β1 (TGF-β1) in precartilaginous stem cell (PSC) proliferation, and to study the underlying mechanisms. We successfully purified and primary-cultured PSCs from the neonate mice' perichondrial mesenchyme, and their phenotype was confirmed by the PSC marker fibroblast growth factor receptor-3 (FGFR-3) overexpression. We found that TGF-β1 induced Akt-glycogen synthase kinase-3β (GSK3β) phosphorylation and β-catenin nuclear translocation in the mouse PSCs, which was almost blocked by TGF-β receptor-II (TGFRII) shRNA knockdown. Further, perifosine and MK-2206, two Akt-specific inhibitors, suppressed TGF-β1-induced GSK3β phosphorylation and β-catenin nuclear translocation. Akt inhibitors, as well as β-catenin shRNA knockdown largely inhibited TGF-β1-stimulated cyclin D1/c-myc gene transcription and mouse PSC proliferation. Based on these results, we suggest that TGF-β1 induces Akt activation to promote β-catenin nuclear accumulation, which then regulates cyclin D1/c-myc gene transcription to eventually promote mouse PSC proliferation.
BibTeX
@article{cheng2014transforming,
  author = {Li Cheng and Chengyu Zhang and Ding Li and Jian Zou and Junfang Wang},
  title = {{Transforming Growth Factor-β1 (TGF-β1) Induces Mouse Precartilaginous Stem Cell Proliferation through TGF-β Receptor II (TGFRII)-Akt-β-Catenin Signaling}},
  journal = {International Journal of Molecular Sciences},
  year = {2014},
  doi = {10.3390/ijms150712665},
}
Figure